Jie Xiong Selected Research

Jie Xiong Research Topics

Disease

68	Neoplasms (Cancer) 01/2022 - 03/2007
9	Inflammation (Inflammations) 01/2022 - 02/2013
8	Neoplasm Metastasis (Metastasis) 12/2021 - 02/2013
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 12/2011
7	Lymphoma (Lymphomas) 01/2022 - 06/2012
7	Fibrosis (Cirrhosis) 01/2022 - 01/2012
6	Lung Neoplasms (Lung Cancer) 12/2021 - 02/2017
6	Infections 03/2021 - 01/2016
6	Carcinogenesis 01/2021 - 10/2014
6	Necrosis 01/2020 - 09/2009
6	Pancreatitis 01/2017 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
5	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2016
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 04/2017
4	Wounds and Injuries (Trauma) 01/2021 - 01/2014
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2008
4	Diabetic Cardiomyopathies 01/2021 - 01/2019
4	Glioblastoma (Glioblastoma Multiforme) 02/2019 - 01/2013
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019 - 01/2013
4	Stomach Neoplasms (Stomach Cancer) 01/2017 - 02/2013
3	Non-alcoholic Fatty Liver Disease 01/2022 - 09/2021
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2020 - 02/2018
3	Disease Progression 01/2020 - 12/2018
3	Seizures (Absence Seizure) 11/2016 - 04/2006
3	Leukemia 04/2016 - 08/2008
3	Burns 02/2015 - 10/2005
2	Cough 06/2022 - 01/2021
2	Fever (Fevers) 06/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 09/2021
2	Lymphopenia (Lymphocytopenia) 01/2022 - 01/2021
2	Obesity 01/2022 - 01/2012
2	Cognitive Dysfunction 01/2022 - 12/2019
2	Adenocarcinoma of Lung 03/2021 - 01/2018
2	Hyperglycemia 01/2021 - 01/2019
2	Hypoxia (Hypoxemia) 01/2021 - 07/2015
2	Glioma (Gliomas) 01/2021 - 03/2007
2	Acute Lung Injury 01/2021 - 01/2020
2	Critical Illness (Critically Ill) 01/2021 - 11/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 11/2016
2	Adenocarcinoma 01/2021 - 12/2016
2	Hemolysis 11/2020 - 10/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2020 - 07/2013

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 03/2021 - 04/2011
15	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2013
11	Messenger RNA (mRNA)IBA 03/2021 - 08/2008
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
8	Pharmaceutical PreparationsIBA 01/2022 - 12/2011
8	EnzymesIBA 01/2022 - 09/2009
8	Biological ProductsIBA 10/2021 - 02/2016
8	Therapeutic UsesIBA 01/2021 - 04/2008
7	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2015
7	CytokinesIBA 11/2020 - 04/2006
7	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2012 - 03/2007
6	Small Interfering RNA (siRNA)IBA 01/2021 - 02/2013
6	LigandsIBA 11/2020 - 12/2011
5	Prorenin ReceptorIBA 01/2021 - 01/2019
5	CollagenIBA 01/2021 - 02/2015
5	Interleukin-6 (Interleukin 6)IBA 11/2020 - 02/2013
4	LipopolysaccharidesIBA 01/2022 - 01/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 02/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2007
3	Insulin (Novolin)FDA Link 01/2022 - 01/2019
3	Long Noncoding RNAIBA 02/2021 - 04/2017
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 01/2016
3	Sulfalene (Longum)IBA 01/2020 - 01/2019
3	SuspensionsIBA 01/2020 - 07/2013
3	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 10/2018
3	ChemokinesIBA 10/2017 - 02/2013
3	Chemokine ReceptorsIBA 02/2017 - 02/2016
3	CeruletideIBA 01/2017 - 01/2013
3	Horseradish PeroxidaseIBA 04/2011 - 09/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 02/2017
2	AutoantibodiesIBA 01/2022 - 01/2020
2	Asparaginase (Elspar)FDA Link 01/2022 - 10/2021
2	LipidsIBA 01/2022 - 01/2022
2	CalciumIBA 01/2022 - 01/2022
2	Phosphorus (Red Phosphorus)IBA 01/2022 - 12/2021
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 12/2021 - 01/2019
2	Glutathione (Reduced Glutathione)IBA 10/2021 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2021
2	Histones (Histone)IBA 01/2021 - 01/2020
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021 - 01/2020
2	LuciferasesIBA 01/2021 - 04/2011
2	Histone DemethylasesIBA 01/2021 - 08/2020
2	Nucleic AcidsIBA 01/2021 - 11/2020
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2020
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2020 - 01/2018
2	Environmental Pollutants (Pollutants, Environmental)IBA 11/2020 - 01/2014
2	LuteolinIBA 10/2020 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 12/2011
2	Lysine (L-Lysine)FDA Link 08/2020 - 01/2020
2	Indicators and Reagents (Reagents)IBA 02/2020 - 10/2017
2	Heme Oxygenase-1IBA 01/2020 - 01/2020

Therapy/Procedure

25	Therapeutics 01/2022 - 09/2009
10	Radiotherapy 02/2019 - 03/2007
7	Drug Therapy (Chemotherapy) 03/2020 - 11/2016
3	Aftercare (After-Treatment) 06/2022 - 01/2020
2	Immunotherapy 01/2022 - 06/2012
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 05/2018